Effective January 2023, all health care providers with a DEA registration that includes Schedule III authority can prescribe buprenorphine to treat patients with Opioid Use Disorder. An X-Waiver is no longer required to prescribe buprenorphine. This change follows the passage of the Mainstreaming Addiction Treatment (MAT) Act in December 2022.
In addition, per the Medication Access and Training Expansion (MATE) Act, starting June 27, 2023 all health care practitioners who apply newly for or seek to renew their DEA registration will be required to complete 8 hours of relevant accredited education related to the prevention, recognition, and care of people with substance use disorders. The 8 hours can be satisfied through a combination of activities and do not have to be included in one session.
For more information, including links to SHM activities that count towards the attestation of training completion, please visit DEA Licensure Requirement.
How did we get here?
In 2000, Congress passed the Drug Addiction Treatment Act (DATA 2000), which created the X-Waiver program to enable waivered clinicians to prescribe buprenorphine outside of methadone clinics and similar settings. Because the X-Waiver required additional steps and training, Medication-Assisted Treatment (MAT) with buprenorphine has been underutilized. Since 2018, SHM has advocated for the elimination of the X-Waiver so that hospitalists can more effectively treat patients with opioid use disorder and be able to prescribe this lifesaving medication at discharge.
In December 2022, the omnibus funding package signed by President Joe Biden effectively cancelled the X-Waiver requirements for physicians and NPs/PAs to prescribe buprenorphine.
Below are statements from the SAMHSA:
Webinar Recording: How to be a Hospitalist Opioid Use Disorder Champion: Improving the Quality of Care for Patients
Recorded on January 28, 2025, this webinar discusses the current state of addiction medicine and the roles that hospitalists can take within their practice to overcome barriers and improve the quality of care for their patients with opioid use disorder. Topics include how to screen patients, building protocols and pathways, QI projects, orders for discharge, and linkage to care. Additionally, speakers discuss how to acquire data on the issue and how to start building capacity within the hospitalist team.
View Recording
Webinar Recording: How to be a Hospitalist Opioid Use Disorder Champion: OUD Consult Services
Recorded on Thursday, February 13, 2025, this webinar focuses on the creation of OUD consult services. In addition to the structure of these service lines, we explore the role that culture plays in OUD treatment. Participants will understand how to assess readiness for consult services within their own institutions, develop support and find partners, define metrics, and activate the model. We also discuss various funding opportunities for these programs.
Articles about OUD Treatment